Search results
Blake Borgeson Sells 11,447 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock
ETF DAILY NEWS· 1 day agoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 11,447 shares of the business’s stock in a transaction dated Tuesday, June 11th ...
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 3 days agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Pharmaceutical company Eli Lilly opens Concord campus
WSOC-TV Charlotte· 2 days agoA major resource for Concord with hundreds of high-paying jobs has opened its doors. Eli Lilly and ...
West Pharmaceutical Services, Inc. (NYSE:WST) SVP Sells $595,404.00 in Stock
ETF DAILY NEWS· 2 days agoWest Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) SVP Silji Abraham sold 1,800 shares of the stock in a transaction on Wednesday, June 12th. The shares were ...
Firm grows local presence with $10M upgrade to drug testing facility - Baltimore Business Journal
The Business Journals· 3 days agoAn international pharmaceutical company has invested $10 million into upgrades at a Baltimore...
RBC lifts Regeneron stock PT to $1,229 on higher sales estimetes of Dupixent By Investing.com
Investing.com· 4 days agoOn Wednesday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) saw an increase in its price target to...
London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug...
Digital Journal· 6 days agoIn addition to LRP-661, the company has generated preclinical data on various compounds targeting a spectrum of diseases, including inflammation, infectious diseases, oncology ...
Madrigal Pharmaceuticals senior VP sells $570,000 in stock By Investing.com
Investing.com· 2 days agoWaltermire, Senior Vice President and Chief of Pharmaceutical Development at Madrigal ...
Is Eli Lilly the Best Pharmaceutical Stock for You?
The Motley Fool via AOL· 4 days agoAnd breast cancer drug Verzenio posted a 40% increase in sales to more than $1 billion. All of... you're an aggressive or cautious investor, it's always...
Eli Lilly stock hits all-time high: What’s been driving the pharma giant’s share price higher?
Bankrate via AOL· 4 days agoAcquisitions, such as that of cancer drug maker POINT Biopharma Global in December 2023, are seen as...